1. Tesamorelin
Class: Synthetic analog of growth hormone–releasing hormone (GHRH)
Primary Research Focus:
-
Hypothalamic–pituitary signaling
-
Pulsatile GH secretion dynamics
-
GHRH receptor pharmacology
Mechanistic Context (Preclinical):
-
Binds GHRH receptor (GHRH-R) on pituitary somatotrophs
-
Activates Gs → cAMP → PKA signaling
-
Stimulates transcription and release of endogenous GH
Tesamorelin is widely used to study physiologic GH pulse amplification rather than direct GH replacement.
2. Ipamorelin
Class: Growth hormone secretagogue (GHS)
Primary Research Focus:
-
Ghrelin receptor (GHS-R1a) signaling
-
GH release with minimal secondary endocrine activation
-
Neuroendocrine specificity of GHS compounds
Mechanistic Context (Preclinical):
-
Selective agonist of GHS-R1a
-
Primarily activates Gq/11-linked calcium signaling
-
Triggers GH release with minimal ACTH, cortisol, or prolactin signaling in comparative models
Ipamorelin is frequently studied for its signaling selectivity among ghrelin-mimetic peptides.